Substance Use Initiation, Particularly Alcohol, in Drug-Naive Adolescents: Possible Predictors and Consequences From a Large Cohort Naturalistic Study.


Journal

Journal of the American Academy of Child and Adolescent Psychiatry
ISSN: 1527-5418
Titre abrégé: J Am Acad Child Adolesc Psychiatry
Pays: United States
ID NLM: 8704565

Informations de publication

Date de publication:
05 2021
Historique:
received: 04 09 2019
revised: 14 07 2020
accepted: 25 09 2020
pubmed: 5 10 2020
medline: 29 5 2021
entrez: 4 10 2020
Statut: ppublish

Résumé

It is unclear whether deviations in brain and behavioral development, which may underpin elevated substance use during adolescence, are predispositions for or consequences of substance use initiation. Here, we examine behavioral and neuroimaging indices at early and mid-adolescence in drug-naive youths to identify possible predisposing factors for substance use initiation and its possible consequences. Among 304 drug-naive adolescents at baseline (age 14 years) from the IMAGEN dataset, 83 stayed drug-naive, 133 used alcohol on 1 to 9 occasions, 42 on 10 to 19 occasions, 27 on 20 to 39 occasions, and 19 on >40 occasions at follow-up (age 16 years). Baseline measures included brain activation during the Monetary Incentive Delay task. Data at both baseline and follow-up included measures of trait impulsivity and delay discounting. From baseline to follow-up, impulsivity decreased in the 0 and 1- to 9-occasions groups (p < .004), did not change in the 10- to 19-occasions and 20- to 29-occasions groups (p > .294), and uncharacteristically increased in the >40-occasions group (p = .046). Furthermore, blunted medial orbitofrontal cortex activation during reward outcome at baseline significantly predicted higher alcohol use frequency at follow-up, above and beyond behavioral and clinical variables (p = .008). These results suggest that the transition from no use to frequent drinking in early to mid-adolescence may disrupt normative developmental changes in behavioral control. In addition, blunted activity of the medial orbitofrontal cortex during reward outcome may underscore a predisposition toward the development of more severe alcohol use in adolescents. This distinction is clinically important, as it informs early intervention efforts in preventing the onset of substance use disorder in adolescents.

Identifiants

pubmed: 33011213
pii: S0890-8567(20)31951-1
doi: 10.1016/j.jaac.2020.08.443
pii:
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

623-636

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH115332
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH096027
Pays : United States
Organisme : MRF
ID : MRF_MRF-058-0004-RG-DESRI
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R00465X/1
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R56 AG058854
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH122394
Pays : United States
Organisme : NIDA NIH HHS
ID : K01 DA043615
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA049238
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH107558
Pays : United States
Organisme : Medical Research Council
ID : MR/S020306/1
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH085772
Pays : United States
Organisme : MRF
ID : MRF_MRF-058-0009-RG-DESR-C0759
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N000390/1
Pays : United Kingdom
Organisme : NCATS NIH HHS
ID : KL2 TR001435
Pays : United States
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States
Organisme : NIDA NIH HHS
ID : R03 DA025796
Pays : United States

Investigateurs

Michael Rapp (M)
Eric Artiges (E)
Sophia Schneider (S)
Tomas Paus (T)
Alexis Barbot (A)
Gareth Barker (G)
Arun Bokde (A)
Nora Vetter (N)
Christian Büchel (C)
Anna Cattrell (A)
Patrick Constant (P)
Penny Gowland (P)
Hans Crombag (H)
Jeffrey Dalley (J)
Benjamin Decideur (B)
Tade Spranger (T)
Tamzin Ripley (T)
Nadja Heym (N)
Herta Flor (H)
Wolfgang Sommer (W)
Birgit Fuchs (B)
Jürgen Gallinat (J)
Hugh Garavan (H)
Rainer Spanagel (R)
Mehri Kaviani (M)
Bert Heinrichs (B)
None Andreas Heinz
Naresh Subramaniam (N)
Tianye Jia (T)
Albrecht Ihlenfeld (A)
James Ireland (J)
Bernd Ittermann (B)
Patricia Conrod (P)
Tobias Banaschewski (T)
Jennifer Jones (J)
Arno Klaassen (A)
Christophe Lalanne (C)
Dirk Lanzerath (D)
Claire Lawrence (C)
Hervé Lemaitre (H)
Sylvane Desrivieres (S)
Catherine Mallik (C)
Karl Mann (K)
Adam Mar (A)
Lourdes Martinez-Medina (L)
Jean-Luc Martinot (JL)
Eva Mennigen (E)
Fabiana Mesquita de Carvahlo (F)
Yannick Schwartz (Y)
Ruediger Bruehl (R)
Kathrin Müller (K)
Frauke Nees (F)
Charlotte Nymberg (C)
Mark Lathrop (M)
Trevor Robbins (T)
Zdenka Pausova (Z)
Jani Pentilla (J)
Francesca Biondo (F)
Jean-Baptiste Poline (JB)
Luise Poustka (L)
Sabina Millenet (S)
Michael Smolka (M)
Juliane Fröhner (J)
Maren Struve (M)
Steve Williams (S)
Thomas Hübner (T)
Uli Bromberg (U)
Semiha Aydin (S)
John Rogers (J)
Alexander Romanowski (A)
Christine Schmäl (C)
Dirk Schmidt (D)
Stephan Ripke (S)
Mercedes Arroyo (M)
Florian Schubert (F)
Yolanda Pena-Oliver (Y)
Mira Fauth-Bühler (M)
Xavier Mignon (X)
Robert Whelan (R)
Claudia Speiser (C)
Tahmine Fadai (T)
Dai Stephens (D)
Andreas Ströhle (A)
Marie-Laure Paillere (ML)
Nicole Strache (N)
David Theobald (D)
Sarah Jurk (S)
Helene Vulser (H)
Ruben Miranda (R)
Juliana Yacubilin (J)
Vincent Frouin (V)
Alexander Genauck (A)
Caroline Parchetka (C)
Isabel Gemmeke (I)
Johann Kruschwitz (J)
Katharina WeiB (K)
Henrik Walter (H)
Jianfeng Feng (J)
Dimitri Papadopoulos (D)
Irina Filippi (I)
Alex Ing (A)
Barbara Ruggeri (B)
Bing Xu (B)
Christine Macare (C)
Congying Chu (C)
Eanna Hanratty (E)
Erin Burke Quinlan (E)
Gabriel Robert (G)
Gunter Schumann (G)
Tao Yu (T)
Veronika Ziesch (V)
Alicia Stedman (A)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

Auteurs

Iliyan Ivanov (I)

Icahn School of Medicine at Mount Sinai, New York. Electronic address: iliyan.ivanov@mssm.edu.

Muhammad A Parvaz (MA)

Icahn School of Medicine at Mount Sinai, New York.

Eva Velthorst (E)

Icahn School of Medicine at Mount Sinai, New York.

Riaz B Shaik (RB)

Icahn School of Medicine at Mount Sinai, New York.

Sven Sandin (S)

Icahn School of Medicine at Mount Sinai, New York; Karolinska Institutet, Stockholm, Sweden.

Gabriela Gan (G)

Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.

Philip Spechler (P)

Laureate Institute for Brain Research, Tulsa, Oklahoma.

Matthew D Albaugh (MD)

of Vermont, Burlington.

Bader Chaarani (B)

of Vermont, Burlington.

Scott Mackey (S)

of Vermont, Burlington.

Tobias Banaschewski (T)

Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.

Arun L W Bokde (ALW)

School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Ireland.

Uli Bromberg (U)

University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Christian Büchel (C)

University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Erin Burke Quinlan (EB)

King's College London, United Kingdom.

Sylvane Desrivières (S)

King's College London, United Kingdom.

Herta Flor (H)

Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany; University of Mannheim, Mannheim, Germany.

Antoine Grigis (A)

NeuroSpin, CEA, Université Paris-Saclay, France.

Penny Gowland (P)

University of Nottingham, University Park, Nottingham, United Kingdom.

Andreas Heinz (A)

12Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.

Bernd Ittermann (B)

Physikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Germany.

Jean-Luc Martinot (JL)

Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000, University Paris Sud, University Paris Descartes - Sorbonne Paris Cité; and Maison de Solenn, Paris, France.

Marie-Laure Paillère Martinot (ML)

Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000, University Paris Sud, University Paris Descartes - Sorbonne Paris Cité; and Maison de Solenn, Paris, France.

Eric Artiges (E)

Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000, University Paris Sud, University Paris Descartes - Sorbonne Paris Cité; and Maison de Solenn, Paris, France.

Herve Lemaitre (H)

Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000, University Paris Sud, University Paris Descartes - Sorbonne Paris Cité; and Maison de Solenn, Paris, France.

Frauke Nees (F)

Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.

Dimitri Papadopoulos Orfanos (DP)

NeuroSpin, CEA, Université Paris-Saclay, France.

Tomáš Paus (T)

University of Toronto, Ontario, M6A 2E1, Canada.

Luise Poustka (L)

University Medical Centre Göttingen, Göttingen, Germany; and the Medical University of Vienna, Vienna, Austria.

Sarah Hohmann (S)

Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.

Sabina Millenet (S)

Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.

Juliane H Fröhner (JH)

Technische Universität Dresden, Dresden, Germany.

Michael N Smolka (MN)

Technische Universität Dresden, Dresden, Germany.

Henrik Walter (H)

12Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.

Robert Whelan (R)

School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Ireland.

Gunter Schumann (G)

King's College London, United Kingdom.

Hugh Garavan (H)

of Vermont, Burlington.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH